PharmaShots Weekly Snapshot (August 20-24, 2018)

  1. Eisai’s and Merck Announces EU’s Marketing Approval of Lenvima (lenvatinib mesylate) for Hepatocellular Carcinoma

Published: 23 Aug,2018 | Tags: Eisai, Merck, Approval, Lenvima, HCC,

  1. Novartis’s Solar-1 trial BYL719 (PI3Ki, alpelisib) meets primary endpoints in advanced or mBC patients

Published: 23 Aug,2018| Tags: Novartis, Solar-1, BYL719, Mbc

  1. AstraZeneca announces Results of AERISTO P-IIIb trial for Bevespi Aerosphere in COPD patients

Published: 23Aug,2018 | Tags: AstraZeneca, Announces, AERISTO P-IIIb, Bevespi Aerosphere, COPD

  1. Shire’s Takhzyro (lanadelumab-flyo) Receives FDA Approval Novel Hereditary Angioedema (HAE) in Age ≥12yrs

Published: 23 Aug,2018 | Tags: Shire, Announces, FDA, Approval, Takhzyro, HAE

  1. Bluebird Bio and Gritstone Oncology signs a Research Collaboration

Published: 23 Aug,2018 | Tags: Bluebird, Gritstone, Research Collaboration, Develop, Novel Cancer Therapies

  1. Pfizer to co-promote Exact Sciences’ Cologuard

Published: 22 Aug,2018 | Tags: Exact, Pfizer, Agreement, Promote, Cologuard

  1. AbbVie Exercises Exclusive Option to License Argenx’s ARGX-115

Published: 22 Aug,2018 | Tags: AbbVie, Argenx, Option to License, ARGX-115

  1. Pfizer and Astellas Amends Clinical Research Protocols of Xtandi for 2 Phase III to treat hormone-sensitive prostate cancer (HSPC)

Published: 22 Aug,2018 | Tags: Pfizer, Astellas, Amends, Protocol, Xtandi P-II, HSPC

  1. Sierra Oncology Acquires Gilead’s Momelotinib to Treat Myelofibrosis for ~$198M

Published: 22 Aug,2018 | Tags: Sierra, Acquires, Momelotinib, from Gilead

  1. Congo Approves Experimental Ebola Treatments by Gilead, Mapp, Toyama Chemical, Regeneron

Published: 22 Aug,2018 | Tags: Congo, Approves, Experimental Treatments, Ebola

  1. Evotec and Novo Nordisk forms collaboration to develop novel small molecule therapies

Published: 22 Aug,2018 | Tags: Evotec, Novo, Research collaboration, for Diabetes, Obesity

  1. GSK Looking to Sell its Indian Consumer Health Unit for ~$4B

Published: 21 Aug,2018 | Tags: GSK, Bids, Horlicks, India Unit

    1. Bio-Thera Announces BLA Acceptance of Humira’s Biosimilar (BAT1406) by China National Drug Administration (CNDA)

Published: 20 Aug,2018 | Tags: Biothera, CNDA, Approval, Humira, Biosimilar BAT1406

  1. Kyowa Announces Ph IIa Results of KW-6356 for Parkinson’s Disorder at IAPRD

Published: 20 Aug,2018 |Tags: Kyowa, P-IIa, Results, KW-6356, PD

  1. Harbour Announces Global Partnership with Kelun-Biotech to Develop and Commercialize A167 (Anti-PD-L1 mAb)

Published: 20 Aug,2018 | Tags:  Harbour, Kelun, Global, Partnership, A167

  1. Merck’s Keytruda (pembrolizumab) Receives Expanded Label Approval for 1L nonsq. mNSCLC, with No EGFR and ALK Genomic Tumor

Published: 20 Aug,2018 | Tags: Merck, FDA, Expanded, Label, Approval, Mnsclc

  1. Organogenesis Reverse Merges with Avista Healthcare Public Acquisition Corp. (AHPAC)

Published: 17 Aug,2018 | Tags: Organogenesis, Acquires, Avista Healthcare

  1. Principia Biopharma files for Initial Public Offering in the US

Published: 17 Aug,2018 |Tags: Principia, Files, IPO, US

  1. Roche’s Alecensa (alectinib) Receives CFDA Priority Review for 1L ALK +ve mNSCLC

Published: 20 Aug,2018 |Tags: Roche, CFDA, Approval, Alecensa, Priority Review, mNSCL

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post